Can the Direct Medical Cost of Chronic Disease Be Transferred across Different Countries? Using Cost-of-Illness Studies on Type 2 Diabetes, Epilepsy and Schizophrenia as Examples

Open Access

Peer-reviewed

Research Article

Lan Gao,

Current address: Deakin Health Economics, Population Health Strategic Research Centre, School of Health & Social Development, Faculty of Health, Deakin University, Burwood, VIC, Australia

Affiliation School of Biomedical Sciences & Pharmacy, The University of Newcastle, Callaghan, NSW, Australia
⨯
Hao Hu,

Affiliation School of Biomedical Sciences & Pharmacy, The University of Newcastle, Callaghan, NSW, Australia
⨯
Fei-Li Zhao,

Current address: Centre for Health Economics Research and Evaluation (CHERE), University of Technology Sydney, Haymarket, NSW, Australia

Affiliation Access and Public Affair, Pfizer Australia, West Ryde, NSW, Australia
⨯
Shu-Chuen Li

* E-mail: ShuChuen.Li@newcastle.edu.au

Affiliation School of Biomedical Sciences & Pharmacy, The University of Newcastle, Callaghan, NSW, Australia
⨯

Reader Comments (0)

Health economics
Is the Subject Area "Health economics" applicable to this article?

Thanks for your feedback.
Metaanalysis
Is the Subject Area "Metaanalysis" applicable to this article?

Thanks for your feedback.
Epilepsy
Is the Subject Area "Epilepsy" applicable to this article?

Thanks for your feedback.
Type 2 diabetes
Is the Subject Area "Type 2 diabetes" applicable to this article?

Thanks for your feedback.
Cost-effectiveness analysis
Is the Subject Area "Cost-effectiveness analysis" applicable to this article?

Thanks for your feedback.
Indirect costs
Is the Subject Area "Indirect costs" applicable to this article?

Thanks for your feedback.
Schizophrenia
Is the Subject Area "Schizophrenia" applicable to this article?

Thanks for your feedback.
Outpatients
Is the Subject Area "Outpatients" applicable to this article?

Thanks for your feedback.